Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients
Loss of the modulatory role of the endothelium may be an important factor in the development of diabetic vascular diseases such as cardiac, cerebral and peripheral vascular disease, as evidenced by changes in the serum lipid profile: increased triglycerides (TG), total lipoprotein cholesterol (...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
São Paulo State University (UNESP)
2012-08-01
|
Series: | Revista de Ciências Farmacêuticas Básica e Aplicada |
Subjects: | |
Online Access: | http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/2045/1264 |
id |
doaj-78c1d9d505dc4119be089f728b72b589 |
---|---|
record_format |
Article |
spelling |
doaj-78c1d9d505dc4119be089f728b72b5892021-04-02T16:35:43ZengSão Paulo State University (UNESP)Revista de Ciências Farmacêuticas Básica e Aplicada1808-45322012-08-01333409414Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patientsLuciana Macatrão Nogueira Nunes0Thiago Moreira de Olinda1Marta Maria de França Fonteles2Miguel Nasser Hissa3Silvânia Maria Mendes de Vasconcelos4Daniel Freire de Sousa5Maria Goretti Rodrigues de Queiroz6Federal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilFederal University of Ceará (UFC), Fortaleza, CE, BrazilLoss of the modulatory role of the endothelium may be an important factor in the development of diabetic vascular diseases such as cardiac, cerebral and peripheral vascular disease, as evidenced by changes in the serum lipid profile: increased triglycerides (TG), total lipoprotein cholesterol (TC) and lowdensity lipoprotein (LDL-C), and reduced highdensity lipoprotein (HDL-C). This article describes a longitudinal intervention study conducted at the Center for Research in Diabetes and Endocrinometabolic Diseases of the Federal University of Ceará (UFC, CE, Brazil), in which 58 patients with type 2 diabetes (DM2) were monitored by recording biochemical parameters during two sessions of laboratory tests, and through monthly interview-based pharmacotherapeutic followup. The study lasted one year and was approved by the human research ethics committee of UFC. The data collected were analyzed with the aid of the program SPSS 11.0. Hypertension was present in 54.4% of patients with DM2, 64% were sedentary and overweight, 44.7% reported having relatives with cardiovascular disease and 59.5% had a family history of diabetes. The serum levels of fasting glucose, TG, TC and LDL-C and the systolic and diastolic blood pressure were reduced after the active follow-up and monitoring of patients. This result reinforces the importance of the role of the pharmacist in the control of biochemical parameters, improvement of patients’ quality of life and prevention of complications.http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/2045/1264Pharmacotherapeutic monitoringDiabetes mellitusBiochemical parameters |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luciana Macatrão Nogueira Nunes Thiago Moreira de Olinda Marta Maria de França Fonteles Miguel Nasser Hissa Silvânia Maria Mendes de Vasconcelos Daniel Freire de Sousa Maria Goretti Rodrigues de Queiroz |
spellingShingle |
Luciana Macatrão Nogueira Nunes Thiago Moreira de Olinda Marta Maria de França Fonteles Miguel Nasser Hissa Silvânia Maria Mendes de Vasconcelos Daniel Freire de Sousa Maria Goretti Rodrigues de Queiroz Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients Revista de Ciências Farmacêuticas Básica e Aplicada Pharmacotherapeutic monitoring Diabetes mellitus Biochemical parameters |
author_facet |
Luciana Macatrão Nogueira Nunes Thiago Moreira de Olinda Marta Maria de França Fonteles Miguel Nasser Hissa Silvânia Maria Mendes de Vasconcelos Daniel Freire de Sousa Maria Goretti Rodrigues de Queiroz |
author_sort |
Luciana Macatrão Nogueira Nunes |
title |
Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
title_short |
Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
title_full |
Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
title_fullStr |
Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
title_full_unstemmed |
Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
title_sort |
monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients |
publisher |
São Paulo State University (UNESP) |
series |
Revista de Ciências Farmacêuticas Básica e Aplicada |
issn |
1808-4532 |
publishDate |
2012-08-01 |
description |
Loss of the modulatory role of the endothelium may
be an important factor in the development of diabetic
vascular diseases such as cardiac, cerebral and
peripheral vascular disease, as evidenced by changes
in the serum lipid profile: increased triglycerides
(TG), total lipoprotein cholesterol (TC) and lowdensity
lipoprotein (LDL-C), and reduced highdensity
lipoprotein (HDL-C). This article describes a
longitudinal intervention study conducted at the Center
for Research in Diabetes and Endocrinometabolic
Diseases of the Federal University of Ceará (UFC, CE,
Brazil), in which 58 patients with type 2 diabetes (DM2)
were monitored by recording biochemical parameters
during two sessions of laboratory tests, and through
monthly interview-based pharmacotherapeutic followup.
The study lasted one year and was approved by the
human research ethics committee of UFC. The data
collected were analyzed with the aid of the program
SPSS 11.0. Hypertension was present in 54.4% of
patients with DM2, 64% were sedentary and overweight,
44.7% reported having relatives with cardiovascular
disease and 59.5% had a family history of diabetes. The
serum levels of fasting glucose, TG, TC and LDL-C and
the systolic and diastolic blood pressure were reduced
after the active follow-up and monitoring of patients.
This result reinforces the importance of the role of the
pharmacist in the control of biochemical parameters,
improvement of patients’ quality of life and prevention
of complications. |
topic |
Pharmacotherapeutic monitoring Diabetes mellitus Biochemical parameters |
url |
http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/2045/1264 |
work_keys_str_mv |
AT lucianamacatraonogueiranunes monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT thiagomoreiradeolinda monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT martamariadefrancafonteles monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT miguelnasserhissa monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT silvaniamariamendesdevasconcelos monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT danielfreiredesousa monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients AT mariagorettirodriguesdequeiroz monitoringbiochemicalmarkersduringpharmacotherapeuticfollowupoftype2diabeticpatients |
_version_ |
1721556138980278272 |